TLSI FY 2025 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$45M+53.4% YoY

Gross Profit

$38M84.6% margin

Operating Income

-$27M-59.7% margin

Net Income

-$39M-86.9% margin

EPS (Diluted)

$-1.84

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$35M

Total Liabilities

$69M

Stockholders' Equity

-$34M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$29M	+53.4%
Gross Profit	$38M	$25M	+50.8%
Operating Income	-$27M	-$36M	+25.5%
Net Income	-$39M	-$33M	-18.0%